Clinical Trials Logo

Decreased Gait Speed clinical trials

View clinical trials related to Decreased Gait Speed.

Filter by:
  • None
  • Page 1

NCT ID: NCT02744391 Completed - Clinical trials for Major Depressive Disorder

A Study of L-DOPA for Depression and Slowing in Older Adults

Start date: August 24, 2016
Phase: Phase 4
Study type: Interventional

Individuals with Late Life Depression (LLD) often have cognitive problems, particularly problems with memory, attention, and problem solving, all of which contribute to antidepressant non-response. Our group and others have shown that decreased thinking speed is the central cause of functional problems in patients with LLD. Similarly, decreased walking speed is associated with depression and carries additional risk for falls, hospitalization, and death. Available evidence suggests that declining functionality in the brain's dopamine system contributes to age-related cognitive and motor slowing. The central hypothesis of this R61/R33 Phased Innovation Award is that by enhancing dopamine functioning in the brain and improving cognitive and motor slowing, administration of carbidopa/levodopa (L-DOPA) will improve depressive symptoms in older adults.